[Efficacy of Lamiophlomis Rotata Capsule in the treatment of type â
¢B prostatitis].
Zhonghua Nan Ke Xue
; 23(12): 1107-1110, 2017 Dec.
Article
em Zh
| MEDLINE
| ID: mdl-29738183
ABSTRACT
OBJECTIVE:
To study the therapeutic effect of Lamiophlomis Rotata Capsule (LRC) in the treatment of type â ¢B prostatitis.METHODS:
We randomly divided 225 patients with type â ¢B prostatitis into an experimental group (n =125) and a control group (n =120), the former treated orally with LRC at 3 capsules tid while the latter with tamsulosin hydrochloride sustained-release capsules at 0.2 mg qd, both for 4 weeks. We compared the therapeutic effects between the two groups of patients based on the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) obtained before, immediately after and at 4 weeks after medication.RESULTS:
A total of 120 patients completed the treatment in the experimental group, which showed remarkable decreases as compared with the baseline in the pain score (5.30 ± 1.23 vs 14.68 ± 1.51, P<0.05), quality of life (QoL) score (6.46 ± 0.93 vs 8.52 ± 1.05, P<0.05) and total NIH-CPSI score (17.50 ± 2.77 vs 27.99 ± 2.98, P<0.05) after 4 weeks of treatment, but no significant change in the urination symptoms score (7.41 ± 1.16 vs 7.16 ± 1.04, P>0.05). The experimental group achieved even markedly lower scores than the controls in the pain symptom (5.30 ± 1.23 vs 13.67 ± 1.49, P<0.05), QoL (6.46 ± 0.93 vs 7.47 ± 0.88, P<0.05) and total NIH-CPSI (17.50 ± 2.77 vs 25.77 ± 2.01, P<0.05) but a higher urination symptoms score than the latter after medication (7.16 ± 1.04 vs 5.68 ± 1.34, P<0.05). At 4 weeks after drug withdrawal, the experimental group also showed significantly lower scores of the pain symptom (7.23 ± 1.03), QoL (6.58 ± 0.87) and total NIH-CPSI (22.18 ± 2.03) than the baseline (all P<0.05) and those in the control group (14.14 ± 0.98, 8.12 ± 0.72 and 26.89 ± 1.67) (all P<0.05). Apart from dizziness in 2 of the patients, who gave up medication halfway, no other obvious adverse reactions were observed during the experiment.CONCLUSIONS:
Lamiophlomis Rotata Capsule deserves to be recommended for the treatment of type â ¢B prostatitis for its safety and effectiveness in reducing the pain and improving the life quality of the patients.Palavras-chave
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Prostatite
/
Medicamentos de Ervas Chinesas
/
Agentes Urológicos
/
Tansulosina
Tipo de estudo:
Clinical_trials
Aspecto:
Patient_preference
Limite:
Humans
/
Male
Idioma:
Zh
Revista:
Zhonghua Nan Ke Xue
Ano de publicação:
2017
Tipo de documento:
Article